Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Best MOTS-c Dosage Endurance 2026: Protocol Comparison

Maintenance 5mg 2x weekly 10mg/week Athletes maintaining high baseline mitochondrial density; off-season or taper phases Sustains existing oxidative capacity without metabolic overload; prevents mitochondrial regression during reduced training volume Ideal for

This comparison does not assign a generated winner or score.

  • Maintenance
  • 5mg
  • 2x weekly
  • 10mg/week
  • Athletes maintaining high baseline mitochondrial density; off-season or taper phases
  • Sustains existing oxidative capacity without metabolic overload; prevents mitochondrial regression during reduced training volume
  • Ideal for established endurance athletes between competition blocks. Prevents decay without risking AMPK desensitisation
  • Active Improvement
  • 10mg
  • 3x weekly
  • 30mg/week
  • General endurance enhancement; VO2max improvement; mitochondrial biogenesis during base-building phases
  • 25–30% increase in oxidative enzyme activity; 15–20% improvement in time-to-exhaustion; enhanced fat oxidation during sub-threshold work
  • Most evidence-supported tier. USC cohort data directly validates this range for measurable performance gains
  • Peak Performance
  • 15mg
  • 45mg/week
  • Competitive athletes in high-volume training blocks; racing phases requiring maximal mitochondrial output
  • Maximal AMPK activation without suppression; supports training loads exceeding 15+ hours/week; accelerates recovery between sessions
  • Reserve for athletes already operating at VO2max >55ml/kg/min. Lower-trained individuals see diminishing returns above 10mg
More references

Related material

Comparison

Comparison with Other Forms

While subcutaneous administration is the standard, alternate forms such as oral or topical are less common due to lower bioavailability and efficacy. Subcutaneous injections ensur…

View details →